Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Abionyx receives ODD for CER-001 to treat LCAT deficiency
CER-001 has been approved to treat LCAT deficiency presenting as kidney dysfunction and/or ophthalmologic disease. Credit: Robina Weermeijer on Unsplash.
CER-001 has been approved to treat LCAT deficiency presenting as kidney dysfunction and/or ophthalmologic disease. Credit: Robina Weermeijer on Unsplash.